BioSpace News Archive

Vaxcyte, Inc. (Nasdaq: PCVX) announced today that the U.S. Food and Drug Administration (FDA) has cleared the Company’s adult Investigational New Drug (IND) application for VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD).

Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in Nature’s Communications Medicine titled “Development of a Blood-Based EV Classifier for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.”

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”) today announced the presentation of translational data at the 2023 Pittsburgh-Ireland International Lung Conference: Precision Medicine in Lung Diseases: From Cellular Mechanisms to Clinical Phenotypes held October 16-17, 2023 at the RCSI University of Medicine and Health Sciences in Dublin, Ireland.

CNS Pharmaceuticals, Inc. announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will participate at the Virtual Investor Ask the CEO Conference on Tuesday, October 24, 2023 at 4:00 PM ET.

Vesigen Therapeutics, Inc. presented data further highlighting the potential of the Company’s non-viral ARMM technology to deliver novel therapeutic payloads to cell and tissue types relevant to multiple therapeutic areas with high unmet need.

According to Vision Research Reports, the U.S. clinical trials market size was valued at USD 23.83 billion in 2022 and is expected to surpass USD 35.1 billion by 2030 with a CAGR of 4.96% from 2022 to 2030.

Vyant Bio, Inc. announced that its special meeting of stockholders on October 19, 2023 was reconvened resulting in the approval of the sale of all or substantially all of the assets of the Company.

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its financial and operating results for the third quarter of 2023 on Thursday, November 9, 2023, at 4:30 p.m. ET.

Surgical Theater is proud to announce a groundbreaking achievement with Stanford Medicine performing the first spine surgery utilizing its augmented reality technology.

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third quarter 2023 after market close on Tuesday, November 7th, 2023.